IFNA17 and chronic myelogenous leukemia, BCR-ABL1 positive: In CML patients, however, favorable effects of IFN-α, such as an increase in NK cell proportions, as well as increased numbers of mature and activated NK cells, and an upregulation of cytotoxicity were described [73,74,75,76].